Shutoku Matsuyama

National Institute of Infectious Diseases — Japan

Medicine · Health Sciences

35h-index8.4kcitations84works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(59), Animal Virus Infections Studies(38), Viral gastroenteritis research and epidemiology(25), COVID-19 Clinical Research Studies(17), Virus-based gene therapy research(12)

Publications84 total

A U508C synonymous mutation in the SARS-CoV-2 deletion hotspot reduces deletion frequency and accelerates viral clearance
mBio·2025Open Access
Biochemical analysis of packing and assembling heptad repeat motifs in the coronavirus spike protein trimer
mBio·2024· 2 citedOpen Access
Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan
Emerging infectious diseases·2024· 4 citedOpen Access
Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2
Influenza and Other Respiratory Viruses·2023· 2 citedOpen Access
Author response for "Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2"
2022
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Nature Communications·2022· 106 citedOpen Access
Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2
2022Open Access
Identification of trypsin-degrading commensals in the large intestine
Nature·2022· 90 citedOpen Access
Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide
PNAS Nexus·2022· 2 citedOpen Access
Hydrophobic Alpha-Helical Short Peptides in Overlapping Reading Frames of the Coronavirus Genome
Pathogens·2022· 3 citedOpen Access
Attenuation of <scp>SARS‐CoV</scp> ‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases
The EMBO Journal·2022· 39 citedOpen Access
Identification of commensals and molecular components mediating trypsin degradation in the large intestine
2022· 1 citedOpen Access
Genome Recombination between Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
2021· 13 citedOpen Access
1) Some problems surfaced by the outbreak of novel coronavirus
Nihon Naika Gakkai Zasshi·2021Open Access
The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection
Journal of Virology·2021· 11 citedOpen Access
The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
Antimicrobial Agents and Chemotherapy·2021· 8 citedOpen Access
Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan
Japanese Journal of Infectious Diseases·2021· 10 citedOpen Access
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
Journal of Virology·2020· 294 citedOpen Access
Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship
The Journal of Infectious Diseases·2020· 2 citedOpen Access
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting viral replication-transcription complex in culture cells
2020· 4 cited
page 1 of 5Next →

Frequent Co-authors

Kazuya Shirato(30), Fumihiro Taguchi(22), Miyuki Kawase(19), Makoto Takeda(10), Naganori Nao(8), Shuetsu Fukushi(8), Makoto Ujike(7), Tsutomu Kageyama(6), Shigeru Morikawa(5), Wataru Kamitani(5), Ikuyo Takayama(4), Noriyo Nagata(3), Hiroshi Katoh(3), Fumihiro Kato(3), Maino Tahara(3), Tadaki Suzuki(3), Tsugunori Notomi(3), Tetsuya Mizutani(3), Masayuki Saijo(3), Ichiro Kurane(3)